Table 1.
Drugs | H.c. McM | H.c. CAVR | RR | p | T.c. McM | T.c. MOX-R | RR | p | O.c. McM | O.c. WAMIRO | RR | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | EC50 (CL) | |||||||
B1a | 0.913 (0.75–1.11) | 2.83 (2.42–3.31) | 3.10 | ⁎ | 3.54 (3.09–4.04) | 56.1 (47.42–66.31) | 15.85 | ⁎ | 3.59 (3.47–4.23) | 15.1 (10.31–22.23) | 4.21 | ⁎ |
B1b | 0.996 (0.73–1.36) | 3.35 (3.01–3.73) | 3.38 | ⁎ | 6.76 (6.25–7.31) | 82.5 (64.14–106.1) | 12.20 | ⁎ | 3.62 (2.92–4.49) | 8.96 (7.577–10.59) | 2.48 | ⁎ |
IVM | 0.635 (0.49–0.83) | 4.21 (3.74–4.73) | 6.63 | ⁎ | 5.57 (4.99–6.22) | 52.5 (44.64–61.64) | 9.43 | ⁎ | 5.58 (5.06–6.16) | 14.3 (10.87–18.85) | 2.56 | ⁎ |
MOX | 0.965 (0.62–1.49) | 2.33 (2.07–2.62) | 2.42 | ⁎ | 7.00 (5.70–8.59) | 50.8 (41.81–61.60) | 7.26 | ⁎ | 5.04 (4.69–5.40) | 5.71 (4.67–6.99) | 1.13 | |
Mil A3 | 0.752 (0.68–0.83) | 6.50 (5.96–7.10) | 8.64 | ⁎ | 8.45 (5.94–12.02) | 271 (215.9–339.4) | 32.07 | ⁎ | 3.56 (2.71–4.68) | 14.7 (12.68–16.3) | 4.13 | ⁎ |
Mil A4 | 0.364 (0.34–0.39) | 3.40 (3.00–3.85) | 9.34 | ⁎ | 4.25 (3.58–5.06) | 123 (108.4–139.4) | 28.94 | ⁎ | 1.77 (1.33–2.36) | 7.09 (5.54–9.07) | 4.01 | ⁎ |
p < 0.0001.